Department of Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands.
Department of Medical Biology and Pathology, University Medical Center Groningen, Groningen, The Netherlands.
Clin J Am Soc Nephrol. 2020 Dec 7;15(12):1740-1748. doi: 10.2215/CJN.07210520. Epub 2020 Nov 17.
ANCA-associated GN is a common cause of rapidly progressive GN, with high relapse rates. The early recognition of an ANCA-associated GN relapse is of importance to prevent loss of kidney function. Urinary soluble CD163 has been identified as a promising marker of active ANCA-associated GN. Previous studies, however, are limited by the lack of histologic data.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We analyzed urinary soluble CD163 in 95 patients with ANCA-associated vasculitis who underwent a kidney biopsy. In total, 125 kidney tissue sections (first kidney biopsy, =67; repeated biopsy, =58) with concurrent 24-hour urine samples were studied. Correlation analyses comparing urinary soluble CD163 levels and morphologic features of ANCA-associated GN were performed using Spearman rank correlation analysis. The diagnostic performance of biomarkers to detect relapsing ANCA-associated GN was evaluated using receiver operating characteristics curve analysis.
High levels of urinary soluble CD163 were found in 96 (87%) of 110 biopsies with active ANCA-associated GN compared with one (7%) of 15 biopsies without active ANCA-associated GN and one (6%) of 17 healthy controls. Urinary soluble CD163 correlated with fibrinoid necrosis (Rho=0.48, <0.001) and cellular crescents (Rho=0.70, <0.001) on kidney biopsy. In repeated biopsies, urinary soluble CD163's sensitivity of 0.94 and specificity of 0.91 for the recognition of relapsing ANCA-associated GN appeared better than routine clinical measures. The presence of CD163 cells in affected glomeruli confirmed urinary soluble CD163's origin.
Urinary soluble CD163 is associated with active ANCA-associated GN and correlates with histologic features as seen in ANCA-associated GN.
This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2020_11_17_CJN07210520_final.mp3.
抗中性粒细胞胞浆抗体(ANCA)相关性肾小球肾炎是快速进展性肾小球肾炎的常见病因,复发率较高。早期识别 ANCA 相关性肾小球肾炎复发对于防止肾功能丧失非常重要。尿液可溶性 CD163 已被确定为一种有前途的活动型 ANCA 相关性肾小球肾炎标志物。然而,之前的研究受到缺乏组织学数据的限制。
设计、设置、参与者和测量:我们分析了 95 例接受肾活检的抗中性粒细胞胞浆抗体相关性血管炎患者的尿液可溶性 CD163。共研究了 125 个肾组织切片(首次肾活检,=67;重复活检,=58)和同时的 24 小时尿液样本。使用 Spearman 等级相关分析比较尿液可溶性 CD163 水平与 ANCA 相关性肾小球肾炎的形态特征。使用受试者工作特征曲线分析评估生物标志物检测复发性 ANCA 相关性肾小球肾炎的诊断性能。
与 15 例无活动型 ANCA 相关性肾小球肾炎的活检和 17 例健康对照相比,96(87%)例活动型 ANCA 相关性肾小球肾炎活检中发现尿液可溶性 CD163 水平较高。与肾活检中的纤维蛋白样坏死(Rho=0.48,<0.001)和细胞性新月体(Rho=0.70,<0.001)相关。在重复活检中,尿液可溶性 CD163 对复发性 ANCA 相关性肾小球肾炎的敏感性为 0.94,特异性为 0.91,优于常规临床指标。受影响肾小球中 CD163 细胞的存在证实了尿液可溶性 CD163 的来源。
尿液可溶性 CD163 与活动型 ANCA 相关性肾小球肾炎相关,并与 ANCA 相关性肾小球肾炎的组织学特征相关。